All News

    What is Breast Cancer Rehab?

    February 4th 2025, 9:21pm

    Article

    Cancer rehab is a fairly new and growing specialty in the therapy world.

    A Patient-Centered Approach to Plastic Surgery Reconstruction

    February 4th 2025, 9:14pm

    Article

    Breast cancer surgery is a deeply personal and often challenging experience for many women.

    Nutrition After a Cancer Diagnosis

    February 4th 2025, 9:10pm

    Article

    If you’re reading this, you recognize the importance of diet and nutrition after a cancer diagnosis.

    Addressing the Unique Challenges of Breast Cancer in People Under 40

    February 4th 2025, 9:06pm

    Article

    Statistics show that breast cancer is most common in women over 50, but that doesn’t mean it can’t affect individuals outside that age range.

    Learn to Advocate for the Cancer Community with Triage Cancer

    February 4th 2025, 8:55pm

    Article

    Join Triage Cancer for their free webinar on Post-Election Advocacy: Getting Engaged.

    Neoadjuvant Tyvyt With Chemo Improve Responses in Resectable, Locally Advanced ESCC

    February 4th 2025, 8:00pm

    Article

    In resectable, locally advanced esophageal squamous cell carcinoma, neoadjuvant Tyvyt plus chemoradiotherapy led to an improvement in response rates.

    When Cancer Makes You Cry, Cry It Out

    February 4th 2025, 6:00pm

    Article

    Even stoics need to cry now and then. My advice from personal experience is this: it is okay to cry.

    World Cancer Day Shines Light on Therapeutic Advancements in Cancer Care

    February 4th 2025, 4:00pm

    Article

    Dr. John Oertle discussed the significance of World Cancer Day, raising awareness about cancer care advancements and improving patient outcomes.

    Weight Gain Measurements May Be Underreported in ALK+ NSCLC Trials

    February 4th 2025, 2:00pm

    Article

    Alecensa weight gain is underreported in ALK+ NSCLC trials, highlighting the need for increased awareness and proactive management of this side effect.

    Tevimbra Plus Chemo May Be Safe, Effective in Advanced Gastric/GEJ Cancer

    February 3rd 2025, 10:00pm

    Article

    Frontline treatment with Tevimbra plus irinotecan, paclitaxel, oxaliplatin and 5-FU/leucovorin had promising efficacy and manageable safety in gastric/GEJ cancer.